• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 1912997
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/02/2020
Event Type  malfunction  
Manufacturer Narrative
The investigation determined higher than expected results were obtained from three different patient samples when tested using vitros tsh reagent lot 6215 on two different vitros 5600 integrated systems.A definitive cause for the higher than expected patient sample results was not established.A vitros tsh lot 6215 reagent issue cannot be ruled out as a contributor to the event, as the results for the same patients were as expected when tested using vitros tsh lot 6170.However, the quality control results on the day of the event were acceptable indicating acceptable vitros tsh lot 6215 reagent performance.Ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros tsh reagent lot 6215.Improper pre-analytical sample handling could have contributed to the higher than expected vitros tsh patient sample results.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.An instrument issue cannot be ruled out as a contributor to the event.No precision testing was conducted on the instruments; therefore the performance of the instruments was not verified and cannot be ruled out as a contributor to the event.No information was provided regarding instrument maintenance, therefore it could not be determined whether the customer was performing maintenance according to protocol.It is possible the customer was not performing adequate maintenance on the instruments, which could lead to issues with vitros tsh results.
 
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solutions center (tsc) to report higher than expected vitros tsh results obtained from three different patient samples when tested using vitros tsh reagent lot 6215 on two different vitros 5600 integrated systems.The vitros tsh lot 6215 patient sample results were deemed higher than expected when compared to results obtained from vitros tsh lot 6170 testing.The vitros tsh lot 6215 patient sample results were deemed higher than expected when compared to results obtained from vitros tsh lot 6170 testing.J1 ¿ (b)(6), patient a results of 0.35 and 0.154 miu/l (lot 6215) versus the vitros tsh lot 6170 result of 0.06 miu/l.J2 ¿ (b)(6), patient a result of 0.159 miu/l (lot 6215) versus the vitros tsh lot 6170 result of 0.06 miu/l.J1 ¿ (b)(6), patient b result of 0.131 miu/l (lot 6215) versus the vitros tsh lot 6170 result of 0.06 miu/l.J1 ¿ (b)(6), patient c result of 0.102 miu/l (lot 6215) versus the vitros tsh lot 6170 result of 0.28 miu/l.J2 ¿ (b)(6), patient c result of 0.49 miu/l (lot 6215) versus the vitros tsh lot 6170 result of 0.28 miu/l.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The higher than expected vitros tsh patient sample results were not reported from the laboratory and ortho has not been made aware of any allegation of patient harm as a result of this event.This report is number 2 of 2 mdr¿s for this event.Two (2) 3500a forms are being submitted for this event as 2 devices were involved.This report corresponds to ortho clinical diagnostics inc.Complaint numbers (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key10314896
MDR Text Key243710397
Report Number3007111389-2020-00081
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 07/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/22/2021
Device Catalogue Number1912997
Device Lot Number6215
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 07/02/2020
Initial Date FDA Received07/23/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/08/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-